Skip to main content
NCBI home page
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2003 Feb 3;24(12):1987–1997. doi: 10.1016/S0149-2918(02)80093-5

The seasonality of rhinovirus infections and its implications for clinical recognition

Arnold S Monto 1,*
PMCID: PMC7133757  PMID: 12581541

Abstract

Background: Rhinoviruses are the most common cause of acute respiratory infections. Isolation of rhinoviruses occurs in a distinct and consistent seasonal pattern that can be used to help determine whether an acute respiratory illness is caused by a rhinovirus.

Objective: This article reviews information on the seasonality of rhinovirus infection derived from early and recent studies of rhinovirus occurrence and treatment.

Methods: PubMed was searched from 1965 to the present to identify all potentially relevant papers. The search terms used were rhinovirus and seasonality. A total of 1998 papers were screened.

Results: Rhinoviruses comprise more than three quarters of viruses circulating in early autumn. In some years and perhaps some geographic areas, spring is an even more important time for rhinovirus transmission. Although overall rates of respiratory illness are lower in summer, rhinoviruses are the most frequently isolated virus at this time of year. Other viral agents, including influenza viruses and respiratory syncytial virus (particularly with parainfluenza virus), predominate in the winter. Thus, for most of the year, rhinoviruses are the cause of the majority of acute viral respiratory infections.

Conclusion: Understanding the seasonal incidence of rhinovirus infection may help determine how best to employ currently available antirhinoviral agents in patients presenting with symptoms of an acute viral respiratory infection.

Keywords: rhinovirus, acute viral respiratory infection

References

  • 1.Adams PF, Hendershot GE, Marano MA. National Center for Health Statistics; 1999. Current estimates from the National Health Interview Survey, 1996; p. 10. (Vital Health Stat). [PubMed] [Google Scholar]
  • 2.Van Volkinburgh VA, Frost WH. Acute minor respiratory diseases prevailing in a group of families residing in Baltimore, Maryland, 1928–1930: Prevalence, distribution and clinical description of observed cases. Am J Hyg. 1993;17:122–153. [Google Scholar]
  • 3.Lidwell OM, Sommerville T. Observations on the incidence and distribution of the common cold in a rural community during 1948 and 1949. J Hyg (Lond) 1951;49:365–381. doi: 10.1017/s0022172400066699. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Badger GF, Dingle JH, Feller AE. A study of illness in a group of Cleveland families. II. Incidence of the common respiratory diseases. Am J Hyg. 1953;58:31–40. doi: 10.1093/oxfordjournals.aje.a119588. [DOI] [PubMed] [Google Scholar]
  • 5.Gwaltney JM, Jr, Jordan WS., Jr Rhinovirus and respiratory disease. Bacteriol Rev. 1964;28:409–422. doi: 10.1128/br.28.4.409-422.1964. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Monto AS, Johnson KM. A community study of respiratory infections in the tropics. II. The spread of six rhinovirus isolates within the community. Am J Epidemiol. 1968;88:55–68. doi: 10.1093/oxfordjournals.aje.a120867. [DOI] [PubMed] [Google Scholar]
  • 7.Ketler A, Hall CE, Fox JP. The Virus Watch program: A continuing surveillance of viral infections in metropolitan New York families. 8. Am J Epidemiol. 1969;90:244–254. doi: 10.1093/oxfordjournals.aje.a121067. [DOI] [PubMed] [Google Scholar]
  • 8.Monto AS, Cavallaro JJ. The Tecumseh Study of Respiratory Illness. IV. Prevalence of rhinovirus serotypes, 1966–1969. Am J Epidemiol. 1972;96:352–360. doi: 10.1093/oxfordjournals.aje.a121466. [DOI] [PubMed] [Google Scholar]
  • 9.Johnston SL, Sanderson G, Pattemore PK. Use of polymerase chain reaction for diagnosis of picornavirus infection in subjects with and without respiratory symptoms. J Clin Microbiol. 1993;31:111–117. doi: 10.1128/jcm.31.1.111-117.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Hyppia T, Puhakka T, Ruuskanen O. Molecular diagnosis of human rhinovirus infections: Comparison with virus isolation. J Clin Microbiol. 1998;36:2081–2083. doi: 10.1128/jcm.36.7.2081-2083.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Rotbart HA. Antiviral therapy for enteroviruses and rhinoviruses. Antivir Chem Chemother. 2000;11:261–271. doi: 10.1177/095632020001100402. [DOI] [PubMed] [Google Scholar]
  • 12.Hayden FG, Coats T, Kim K. Oral pleconaril treatment of picornavirus-associated viral respiratory illness in adults: Efficacy and tolerability in phase II clinical trials. Antivir Ther. 2002;7:53–65. [PubMed] [Google Scholar]
  • 13.Hayden FG, Kin M, Villano SA, Pleconaril Respiratory Infection Study Group . October 25–28, 2001. Pleconaril treatment provides early reduction of symptom severity in viral respiratory infection due to picornaviruses. (Program and abstracts of the 39th Annual Meeting of the Infectious Diseases Society of America). San Francisco, Calif. [Google Scholar]
  • 14.Monto AS, Bryan ER, Ohmit S. Rhinovirus infections in Tecumseh, Michigan: Frequency of illness and number of serotypes. J Infect Dis. 1987;156:43–49. doi: 10.1093/infdis/156.1.43. [DOI] [PubMed] [Google Scholar]
  • 15.Pitkaranta A, Virolainen A, Jero J. Detection of rhinovirus, respiratory syncytial virus, and coronavirus infections in acute otitis media by reverse transcriptase polymerase chain reaction. Pediatrics. 1998;102:291–295. doi: 10.1542/peds.102.2.291. [DOI] [PubMed] [Google Scholar]
  • 16.Nicholson KG, Kent J, Ireland DC. Respiratory viruses and exacerbations of asthma in adults. BMJ. 1993;307:982–986. doi: 10.1136/bmj.307.6910.982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Nicholson KG, Kent J, Hammersley V, Cancio E. Risk factors for lower respiratory complications of rhinovirus infections in elderly people living in the community: Prospective cohort study. BMJ. 1996;313:1119–1123. doi: 10.1136/bmj.313.7065.1119. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Monto AS, Ross H. Acute respiratory illness in the community: Effect of family composition, smoking, and chronic symptoms. Br J Prev Soc Med. 1977;31:101–108. doi: 10.1136/jech.31.2.101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Makela MJ, Puhakka T, Ruuskanen O. Viruses and bacteria in the etiology of the common cold. J Clin Microbiol. 1998;36:539–542. doi: 10.1128/jcm.36.2.539-542.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Arruda E, Pitkaranta A, Witek TJ., Jr Frequency and natural history of rhinovirus infections in adults during autumn. J Clin Microbiol. 1997;35:2864–2868. doi: 10.1128/jcm.35.11.2864-2868.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Monto AS, Cavallaro JJ. The Tecumseh Study of Respiratory Illness. II. Patterns of occurrence of infection with respiratory pathogens, 1965–1969. Am J Epidemiol. 1971;94:280–289. doi: 10.1093/oxfordjournals.aje.a121321. [DOI] [PubMed] [Google Scholar]
  • 22.Monto AS, Sullivan KM. Acute respiratory illness in the community. Frequency of illness and the agents involvedEpidemiol Infect. 1993;110:145–160. doi: 10.1017/s0950268800050779. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Johnston SL, Pattemore PK, Sanderson G. Community study of role of viral infections in exacerbations of asthma in 9–11 year old children. BMJ. 1995;310:1225–1229. doi: 10.1136/bmj.310.6989.1225. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Monto AS, Koopman JS, Longini IM., Jr Tecumseh Study of Illness. XIII. Influenza infection and disease, 1976–1981. Am J Epidemiol. 1985;121:811–822. doi: 10.1093/oxfordjournals.aje.a114052. [DOI] [PubMed] [Google Scholar]
  • 25.Syndenstricker E. A study of illness in a general population group. Hagerstown Morbidity Studies No. I: The method and general resultsPublic Health Rep. 1926;41:2069–2088. [Google Scholar]
  • 26.Frost WH, Gover M. The incidence and time distribution of common colds in several groups kept under continuous observation. Public Health Rep. 1932;47:1815–1841. [Google Scholar]
  • 27.Dingle JH, Badger GF, Jordan WS., Jr . Western Reserve University Press; Cleveland, Ohio: 1964. (Illness in the Home: A Study of 25,000 Illnesses in a Group of Cleveland Families). [Google Scholar]
  • 28.Monto AS, Ullman BM. Acute respiratory illness in an American community. The Tecumseh StudyJAMA. 1974;227:164–169. [PubMed] [Google Scholar]
  • 29.Larsen HE, Reed SE, Tyrell DAJ. Isolation of rhinoviruses and coronaviruses from 38 colds in adults. J Med Virol. 1980;5:221–229. doi: 10.1002/jmv.1890050306. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Gwaltney JM, Jr, Hendley JO, Simon G, Jordan WS., Jr Rhinovirus infections in an industrial population. I. The occurrence of illness. N Engl J Med. 1966;275:1261–1268. doi: 10.1056/NEJM196612082752301. [DOI] [PubMed] [Google Scholar]
  • 31.Fox JP, Cooney MK, Hall CE. The Seattle Virus Watch. V. Epidemiologic observations of rhinovirus infections, 1965–1969, in families with young children. Am J Epidemiol. 1975;101:122–143. doi: 10.1093/oxfordjournals.aje.a112078. [DOI] [PubMed] [Google Scholar]
  • 32.Monto AS, Shope TC, Schwartz SA, Albrecht JK. Intranasal interferon-α2b for seasonal prophylaxis of respiratory infection. J Infect Dis. 1986;154:128–133. doi: 10.1093/infdis/154.1.128. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Monto AS, Albrecht JK, Schwartz SA. Demonstration of dose-response relationship in seasonal prophylaxis of respiratory infections with alpha-2b interferon. Antimicrob Agents Chemother. 1988;32:47–50. doi: 10.1128/aac.32.1.47. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Monto AS, Schwartz SA, Albrecht JK. Ineffectiveness of postexposure prophylaxis of rhinovirus infection with low-dose intranasal alpha 2b interferon in families. Antimicrob Agents Chemother. 1989;33:387–390. doi: 10.1128/aac.33.3.387. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Gwaltney JM, Jr, Hendley JO, Simon G, Jordan WS., Jr Rhinovirus infections in an industrial population. II. Characteristics of illness and antibody response. JAMA. 1967;202:494–500. [PubMed] [Google Scholar]
  • 36.Monto AS, Gravenstein S, Elliott M. Clinical signs and symptoms predicting influenza infection. Arch Intern Med. 2000;160:3243–3247. doi: 10.1001/archinte.160.21.3243. [DOI] [PubMed] [Google Scholar]
  • 37.Boivin G, Hardy I, Tellier G, Maziade J. Predicting influenza infections during epidemics with use of a clinical case definition. Clin Infect Dis. 2000;31:1166–1169. doi: 10.1086/317425. [DOI] [PubMed] [Google Scholar]

Articles from Clinical Therapeutics are provided here courtesy of Elsevier

RESOURCES